Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06838351 · ClinicalTrials.gov registry record · NA
Drawing and Anxiety Study
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 275
- Enrollment target
NCT06838351 is a NA study that has completed, run by Penn State University. The registered enrollment target is 275 participants.
The verdict
NCT06838351, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
Study Summary
Anxiety is among the most common emotional difficulties impacting well-being, highlighting the need for approachable anxiety-reduction tools. Both mindfulness and art-based interventions have been shown to decrease anxiety symptoms. These studies integrate these approaches via a novel guided drawing intervention, and tests effects on anxiety (pre/post drawing and at one-week follow-up) and physiological regulation (respiratory sinus arrhythmia). This registration includes two separate intervention studies with similar protocols but using different samples - one consisting of adolescents ages 13 to 17.9 years, and the other consisting of adults ages 18 to 25 years. Participants complete a laboratory visit during which they complete questionnaires about their emotions and anxiety, complete pre/post measures of cardiac physiology and state anxiety, and engage in a drawing session. Participants also complete a one-week follow-up self-report of anxiety symptoms. The intervention protocol is briefly described as follows: participants in each sample are randomly assigned to one of three groups (guided drawing, free drawing control, or basic control).
Interventions
- BEHAVIORAL Guided Drawing Intervention
- BEHAVIORAL Free Drawing Control
- BEHAVIORAL Basic Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06838351
The ClinicalTrials.gov registry entry for NCT06838351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Guided Drawing Intervention is the first listed.
NCT06838351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06838351 about?
NCT06838351 is a clinical study titled "Drawing and Anxiety Study". Anxiety is among the most common emotional difficulties impacting well-being, highlighting the need for approachable anxiety-reduction tools. Both mindfulness and art-based interventions have been shown to decrease anxiety symptoms. These studies integrate these approaches via a novel guided drawing...
What is the current status of trial NCT06838351?
This trial is currently completed. It is a NA study. The enrollment target is 275 participants. The study started on 2022-09-29. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT06838351?
The interventions under investigation include: Guided Drawing Intervention (BEHAVIORAL), Free Drawing Control (BEHAVIORAL), Basic Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT06838351?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.